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Military personnel serving in Operation Enduring Freedom (OEF) and Operation Iraqi Freedom 
(OIF) have been exposed to an increased risk of PTSD. Yet no study has used a proper comparison 
group to estimate the effect of deployment intensity on the risk of PTSD. This study estimates the 
effect of deployment location and length on the risk of being diagnosed with PTSD, relative to what 
it would be from the normal military operations. 
 
Methods 
We use a random sample of active-duty personnel serving between 2001 and 2006.  We identify 
PTSD cases from TRICARE medical records and link deployment information from Contingent 
Tracking System.  We compare rates of PTSD diagnoses based on deployment locations across 
services, and estimate logistic regressions to assess the effect of deployment intensity on the rate of 
PTSD.  We also provide a descriptive analysis of the comorbidity distribution among the PTSD 
population.  We conduct separate analyses for enlisted and officer populations. 
 
Results 
Among the enlisted population, comparing to those in other duties around the world, deployment to 
Iraq/Afghanistan increases the odds of developing PTSD substantially, with the largest effect 
observed for the Navy (OR=9.06, p<0.01) and the smallest effect for the Air Force (OR=1.25, 
p<0.01).  A deployment longer than 180 days increases the odds of PTSD by 1.11 times to 2.84 
times, depending on the service, compared to a tour under 120 days. For the Army and the Navy, a 
deployment to Iraq/Afghanistan further exacerbates the adverse effect of tour length.  We observe 
similar adverse effects among the officers although the magnitude of the deployment effect is 
smaller.   
 
Conclusions 
Our research identifies the extent of PTSD across services and quantifies the risks associated with 
OEF/OIF deployment intensity.  Further research is needed for effective monitoring and 
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 Introduction 
Recent research suggests that the wars in Afghanistan and Iraq, also known as Operation 
Enduring Freedom (OEF) and Operation Iraqi Freedom (OIF), pose substantial mental health 
challenges to U.S. military service members and mental health systems (Erbes, Westermeyer, 
Engdahl, & Johnsen, 2007; Hoge, Auchterlonie, & Milliken, 2006; Hoge et al., 2004; R. A. 
Rosenheck & Fontana, 2007; Seal, Bertenthal, Miner, Sen, & Marmar, 2007; Tanielian & Jaycox, 
2008).  Post-traumatic stress disorder (PTSD), in particular, has risen steadily, with heavy combat 
typically being cited as a leading cause of PTSD (CDC, 1988; Helzer, Robins, & McEvoy, 1987; 
Hoge, et al., 2004; Kang, Natelson, Mahan, Lee, & Murphy, 2003; Prigerson, Maciejewski, & 
Rosenheck, 2002; The Iowa Persian Gulf Study Group, 1997).  This study examines the effects of 
the location and duration of OEF/OIF deployments (particularly to Afghanistan and Iraq) on the 
probability of being diagnosed with PTSD for still-active military personnel. 
A recent comprehensive review of the literature by Rand found a wide range of PTSD rates 
among those serving in Iraq and Afghanistan, with estimates ranging from 4% to 45%, depending 
on the samples and how PTSD was measured (Tanielian & Jaycox, 2008). Many studies used 
anonymous survey responses from convenience samples of Army soldiers who were deployed in 
either Iraq or Afghanistan from 2003 to 2005 (Erbes, et al., 2007; Grieger et al., 2006; Helzer, et al., 
1987; Hoge, et al., 2004; Vasterling et al., 2006). Some analyzed the mental health issues using post-
deployment health assessment surveys collected by the Mental Health Advisory Team (MHAT), 
which measured PTSD by primary-care PTSD screening questions (Hoge, et al., 2006; Shen, Arkes, 
& Pilgrim, 2009; U.S. Army, 2003, 2005, 2006a, 2006b), while a few used actual medical records 
from the VA health care system.  
With the Global War on Terrorism going into its 9th year and with a planned surge of forces 
in Afghanistan being considered, it is critical to evaluate the prevalence of PTSD among the active 
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duty population and how the deployment intensity in OEF/OIF affect the mental health readiness 
of the Armed Forces.  While previous studies have provided important information on PTSD in the 
current operations, they have several shortcomings.  First, the previous studies have been descriptive 
analyses except for a study analyzing UK solders and one focusing on the US Navy enlisted 
personnel (Rona et al., 2007; Shen, et al., 2009).  Second, most studies focus on just the Army and 
Marine Corps. Yet the rates of PTSD among those deployed in Iraq and Afghanistan could be 
different across services because of different types of assignments, and such differences are 
important to identify in evaluating total force readiness.  Third, most studies used convenience 
samples on those returning from OEF/OIF, without a comparable control group of personnel who 
were not deployed under OEF/OIF.  Thus, while these studies indicate the frequency of PTSD for 
those deployed under OEF/OIF, they cannot speak to the effect of being deployed under 
OEF/OIF relative to their risk of PTSD under other military operations.  Fourth, studies using 
surveys often had to rely on screening questions (such as PCL-DSM IV), which are typically short 
and simple to administer but likely miss some cases of PTSD and misdiagnose PTSD in other cases 
(Kimerling et al., 2006; Ramchand, Karney, Osilla, Burns, & Caldarone, 2008).  Finally, previous 
studies focus on the effect of the deployment location (i.e, Iraq or Afghanistan) with little attention 
paid to the duration of deployment or the cumulative effect of multiple deployments on the PTSD 
occurrence.  However, deployment duration and frequency are equally important deployment 
dimensions to consider when designing the optimal deployment strategy. 
In this study, we address the shortcomings of the previous literature with a random sample 
based on all active duty personnel serving between 2001 and 2006. We merge data on PTSD 
diagnoses from the TRICARE medical records and deployment records from the Contingency 
Tracking System.  We then examine the effects of OEF/OIF deployment intensity for officer and 
enlisted personnel separately for the four services (Army, Marines, Navy, and Air Force).  We 
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analyze two dimensions of deployment intensity: location and duration.  Lastly, we focus on the 
PTSD population and conduct a descriptive analysis of the severity of their illnesses.  Specifically, we 
address the following research questions:  
1. What are the rates of PTSD diagnoses among all active duty officer and enlisted personnel 
and how do the rates differ by service and deployment characteristics? 
2. How do deployment location and length of deployment affect the probability of being 
diagnosed with PTSD? 
3. Is there an interactive effect between a deployment’s length and location? In particular, do 
longer deployments to Iraq or Afghanistan exacerbate the risk of PTSD? 
4. Among the active duty population who are diagnosed with PTSD, what is the comorbidity 
distribution? 
The statistical methods we use were built upon our prior study that examined deployment 
intensity on the rate of PTSD among Navy personnel.(Shen, et al., 2009)  This study differs in 
several important dimensions.  First, while our prior study examined only sailors, in this study we 
compare the PTSD rates and deployment effects across all four services.  Second, the prior study is 
based on the Post Deployment Health Assessment (PDHA) that were only filled by people who 
were deployed on GWOT missions, thus it cannot compare the rate of PTSD between those who 
were deployed and those who were sent on other missions.  The current study addresses this 
shortcoming as discussed below.  Third, the prior study can only capture PTSD cases right after the 
deployment based on four screening questions (since PHDA has to be filled out 30 days from the 
return of the deployment), while the current study allows us to have a much longer look-forward 
window to capture the PTSD cases and identify PTSD cases through clinical diagnoses.   Lastly, it is 
important to keep in mind that in this study we focus on TRICARE eligible population (i.e., people 
who are still serving in the military during the study period, including ones with PTSD diagnoses), 
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and our results give a sense of the mental health readiness among the still active personnel. 
 
Data and Methods 
Methods Overview.  Our sample is based on all individuals who were active duty service 
members of the US Armed Forces between 2001 and 2006.  The outcome of interest is whether the 
individual was diagnosed with PTSD within the TRICARE system.  We first use a descriptive 
analysis to compare the rate of PTSD among different branches of the Armed Services by 
deployment location.  We then estimate two multivariate models using logistic regressions to assess 
the effect of deployment intensity (location, duration) under OEF/OIF on the rate of PTSD 
diagnoses.  These regression models address the policy question of how much an Iraq/Afghanistan 
(or other OEF/OIF) deployment increases the risk of being diagnosed with PTSD later relative to 
the risk military personnel would have had if they had not been deployed to OEF/OIF missions. 
We estimate our models separately for each service (Army, Air Force, Marines, and Navy) and 
separately for officers and enlisted personnel.  We provide more details on the model specifications 
below.  Lastly, we focus on the PTSD population and study their comorbidity distribution. 
Data and Sample.  We use a random sample of activity-duty personnel serving between 
September 2001 and December 2006 because the GWOT started in 2001 and 2006 is the year for 
which the latest data are available.  We combine several data sources from TRICARE and the 
Defense Manpower Data Center (DMDC) to form the basis of our analysis. First, we identify the 
active duty personnel population and obtain demographic and service information (such as age, 
gender, race, rank) from the Defense Enrollment Eligibility Reporting System (DEERS).  Second, 
depending on where PTSD was diagnosed (military treatment facility or TRICARE civilian provider) 
and whether it was identified from inpatient or outpatient claims, we identify the date that PTSD 
was first diagnosed and related health information from the following sources: the Standard 
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Inpatient Data Record, the Standard Ambulatory Data Record, and the TRICARE Encounter Data.  
Third, we obtain OEF/OIF deployment characteristics and military occupational specialty (MOS) 
codes between 2001 and 2006 from the Contingency Tracking System (CTS). The CTS Deployment 
Files were used to track personnel involved in contingency operations and report all personnel who 
have been deployed in support of GWOT since September 11, 2001.  CTS data contain information 
on deployment location, start and end dates of the deployment.   A person would have multiple sets 
of deployment records in CTS if he were deployed multiple times during the study period. The study 
received expedited IRB approval.  
 Each observation in our data represents unique personnel.  Based on the TRICARE medical 
records and monthly DEERS records, we first identify all personnel who were diagnosed with 
PTSD and take their demographic and rank information from DEERS the month they were 
diagnosed.  Next, for the remaining active duty population (those without PTSD), we randomly 
select a month from each individual’s monthly DEERS records for their demographic and rank 
information.  We then draw a 25 percent random sample of this population from each service 
(regardless of whether they used TRICARE services). For all personnel in our sample, we extract 
complete deployment information from CTS. At the end, our data consist of 678,227 unique 
enlisted personnel and 95873 unique officers from all services.  This represents a 25% random 
sample of the active-duty population without PTSD and 100% of the PTSD population. We weight 
all of our comparisons and empirical models to reflect this sampling scheme so our estimated 
numbers are representative of all personnel from each service.  
Outcome measures. The dependent variable in our analysis is whether an active duty 
person was diagnosed with PTSD anytime between 2001 and 2006 (i.e., if the ICD-9 code of the 
principal diagnosis is 309.81)(American Psychiatric Association, 2000).    
Statistical Models. After an initial set of descriptive analyses for raw comparisons of PTSD 
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rates for different types of deployments across services, we conduct regression models in order to 
control for relevant factors.  Because our outcome is binary, we estimate logistic regression models.  
In the primary models, we focus on deployment characteristics of the last deployment.  For 
example, if a person was included in the analytical sample on March 2004 and his/her most recent 
deployment prior to this date was July 2003, we would use deployment information from the July 
2003 deployment in this set of models.  Our key variables of interest in Model 1 are the deployment 
location and duration (details below).  In Model 2, we estimate an interaction effect between 
deployment duration and deployment location (in particular, Iraq and Afghanistan) to test whether 
longer deployments as a result of OIF and OEF magnifies the effect of such a deployment on the 
probability of being diagnosed with PTSD. 
As a sensitivity analysis on the location effect, we also estimate a model based on the 
locations of all past deployment, since PTSD is not necessarily triggered by the last deployment and 
often emerges or is diagnosed after a long delay. Specifically, if a person was included in the sample 
on March 2004, we identify the locations for all deployments between 2001 and March 2004.  The 
key variable of interest in this sensitivity model is whether a person was ever deployed to a given 
location (details below).  In all models, we control for service and demographic characteristics as 
explained below.  
Explanatory variables.  There are three categories of variables that we include in the 
models: deployment characteristics, service characteristics, and demographic information.   Summary 
statistics of these measures are presented in Table 1.  We describe here the different types of 
variables. 
 We classify three categories of deployment locations: not deployed under OEF or OIF (the 
reference group), deployed to Iraq/Afghanistan, deployed on other OEF/OIF missions (such as 
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Kuwait, Qatar, Saudi Arabia, Turkey).1 For the duration of the last deployment, we classify the 
deployment length into three categories: “short” if the length of the last deployment is less than 120 
days (the reference group), “medium” if the length of last deployment is between 120 and 180 days, 
and “long” if the duration is greater than 180 days.  In the sensitivity analysis, we define four 
mutually exclusive categories of all past deployment location indicators: ever deployed to Iraq or 
Afghanistan (but not other locations), ever deployed on other OEF/OIF missions, ever deployed to 
Iraq/Afghanistan as well as other OEF/OIF missions, and never deployed on any OEF/OIF 
mission (the reference group). 
 For service characteristics, we include rank and military occupation specialty (MOS) 
categories. Studies have shown that soldiers in combat divisions and those in medical service tend to 
have different rates of PTSD than non-combat specialties (Martin, 2007; Tanielian & Jaycox, 2008).  
We categorize military occupational specialty codes into the following categories: Combat arms 
(reference group), combat support, combat service support, aviation, medical, and other MOS.  
Note that the four service branches use different sets of military occupation codes. The Army and 
Marine Corps use a Military Occupational Specialty (MOS) code, while a system of Air Force 
Specialty Codes (AFSC) is used in the Air Force. The Navy uses a system of naval ratings and 
designators along with the Naval Enlisted Classification (NEC) system.  For some service branches, 
some of the categories are merged due to small numbers of observations in the individual categories 
and some categories are missing (for example, Marines and Air Force do not have medical MOS  
To control for demographic characteristics, we include the following demographic 
information in the models: gender, race (with White as the reference group, African-American, 
Hispanic, Asian, and other races), marital status (single or married), and age.  Lastly, we include year 
                                            
1 We do not define more detailed location categories because sample size would be too small for the finer 
categorization. 
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indicators to control for possible macro trends in the PTSD rate in the general active duty 
population.  In the sensitivity analysis section, we also briefly discuss the results in which we take out 




 Characteristics of the Active Duty Enlisted Population.  Table 1 presents the descriptive 
statistics of the enlisted sample by service branches. We focus our discussion on the deployment 
characteristics.  The majority of the active duty personnel were not deployed under OEF/OIF: the 
percentages range from 61.5% in Air Force to 78% in Army.  However, while not shown, this rate 
did vary by year as increasing numbers of Army and Marine Corps personnel were deployed under 
OEF/OIF in later years.  Not surprisingly, the service with the highest share of its enlisted members 
sent to Iraq/Afghanistan is the Army (11.3%), followed by the Marine Corps (8.6%).  The Navy and 
Air Force appear to serve a more supporting role, with 35% and 33%, respectively, of their enlisted 
population being sent on OEF/OIF missions other than to Iraq/Afghanistan.  Among those 
deployed, large proportions of Army and Marine Corps personnel had been deployed more than 180 
days in their most recent deployment prior to being included in the sample (58% and 48%, 
respectively), whereas 65% of deployed Air Force personnel had a tour length under 120 days.   
The next set of summary statistics report the proportions of those ever deployed under 
OEF/OIF who were ever deployed to a given location since September 11, 2001.  We categorize the 
past deployment location indicators into three mutually exclusive categories to allow for easier 
comparison (i.e., the three rows add up to 100%).  With the Army, for example, 31% of solders ever 
deployed under OEF/OIF were sent to Iraq/Afghanistan (but not on other OEF/OIF missions), 
45% were sent on other OEF/OIF missions, and the remaining 24% have been to Iraq/Afghanistan 
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as well as other OEF/OIF missions.   The rest of Table 1 provides summary statistics of service and 
demographic characteristics, which are representative of the US Armed Forces active duty 
population. 
Characteristics of the Active Duty Officer Population.  Table 2 presents the descriptive 
statistics of the officer sample by service branches.  Similar to the enlisted population, the majority 
of the active duty officers were not deployed under OEF/OIF: the percentages range from 62.5% in 
Air Force to 74.7% in Army.  Not surprisingly, the service with the highest share of its officer 
members sent to Iraq/Afghanistan is the Army (10.5%), followed by the Marine Corps (9.0%).   
Similar to the enlisted population, the Navy and Air Force appear to serve a more supporting role, 
with 31.4% and 33%, respectively, of their officer population being sent on OEF/OIF missions 
other than to Iraq/Afghanistan.  Among those deployed, almost half of Army and Marine Corps 
personnel had been deployed more than 180 days in their most recent deployment prior to being 
included in the sample, whereas 72% of deployed Air Force personnel had a tour length under 120 
days. 
 PTSD Rate By Deployment Characteristics.  Table 3 reports the proportion of the active 
duty population who were diagnosed with PTSD for each service, with the top panel presenting 
results of the enlisted population and the bottom panel presenting results of the officer population.  
The first row presents the PTSD percentage for the entire active duty population, regardless of their 
deployment status, and ranges from 0.6% for the Air Force to 1.4% for the Army. The next set 
reports the PTSD rate by the last deployment location.  People deployed to Iraq/Afghanistan had 
much higher rates of being diagnosed with PTSD compared to those not deployed under OEF or 
OIF (4.4% vs. 0.6% for the Army, 3.5% vs. 0.5% for the Marines, 6.5% vs. 0.5% for the Navy, and 
1.3% vs. 0.6% for the Air Force; p<0.01 for statistical tests of all of these differences).  Army and 
Marine Corps personnel deployed on other OEF/OIF missions also have higher rates of PTSD 
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compared to those not deployed under OEF/OIF (3.8% for Army, 2.3% for Marines), but the 
opposite is the case for the Navy and Air Force.  Among those deployed under OEF/OIF, the 
PTSD rate increases as the tour length increases.  With the Army, for example, the proportion of 
enlisted personnel who were later diagnosed with PTSD is 2.9% among those with a short tour 
length (1-120 days), and the rate increases to 3. 5% in the medium length category (120-180 days) 
and to 4.8% for long tours (>180 days).   We observe similar, but not as stark, patterns for the other 
three services.  
The next set of statistics in the top panel of Table 3 reports the PTSD rate by whether a 
person was ever deployed to a given location. With the Army, the proportion of enlisted personnel 
ever deployed to Iraq/Afghanistan (but not on other OEF/OIF missions) who were diagnosed with 
PTSD is 3.5%.  The number is slightly lower for those who were deployed on OEF/OIF missions 
other than to Iraq/Afghanistan (3.4%).  The rate of PTSD is even higher (6.2%) for those who have 
been to Iraq/Afghanistan, as well as on other OEF/OIF missions. We observe similar pattern for 
the other three branches. 
The rate of PTSD is much lower in the officer population (bottom panel of Table 3), with 
the overall PTSD rate ranging from 0.29% in the Air Force to 0.66% in the Army.  People deployed 
to Iraq/Afghanistan had much higher rates of being diagnosed with PTSD compared to those not 
deployed under OEF or OIF although the magnitude difference is not as stark as in the enlisted 
population (1.6% vs. 0.4% for the Army, 1% vs. 0.2% for the Marines, 1.4% vs. 0.2% for the Navy, 
and 0.9% vs. 0.3% for the Air Force; p<0.01 for statistical tests of all of these differences).  Similar 
to the enlisted population, among those deployed under OEF/OIF, the PTSD rate increases as the 
tour length increases.  With the Army, for example, the proportion of officers who were later 
diagnosed with PTSD is 0.90% among those with a short tour length (1-120 days), and the rate 
increases to 1.32% in the medium length category (120-180 days) and to 1.88% for long tours (>180 
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days).   When examining the rate of PTSD by deployment history (the last set of statistics), we 
observe a similar pattern in the officer population as we had in the enlisted population.  For 
example, the proportion of Army officers ever deployed to Iraq/Afghanistan (but not other 
OEF/OIF missions) who were diagnosed with PTSD is 1.45%.  The number is slightly lower for 
those who were deployed on OEF/OIF missions other than to Iraq/Afghanistan (1.26%).  The rate 
of PTSD almost doubles for those who have been to Iraq/Afghanistan and on other OEF/OIF 
missions. We observe similar pattern in Marines and Navy, but not in Air Force. 
 Multivariate Analysis of Deployment Intensity on PTSD Rates—Enlisted Population.  
The raw proportions of personnel being diagnosed with PTSD shown in Table 3 provide a good 
comparison across services of the prevalence of PTSD based on types of deployments.  We next 
report, in Table 4, the logistic regression results that compare, across services, the effect of the 
OEF/OIF deployment on the risk of being diagnosed with PTSD relative to the risk enlisted 
personnel would have had in the more typical military missions around the world.  We present the 
results in terms of odds ratios and focus only on the effects of deployment characteristics in Table 4 
(the complete regression results for Model 1 are included in the Appendix).  The top panel of Table 
4 reports the main effect of the last deployment’s location and duration.  With the Army, the first 
row indicates that the odds of being diagnosed with PTSD is 3.96 times higher among those 
deployed to Iraq/Afghanistan compared to those not deployed under OEF/OIF (p<0.01).  Being 
deployed on other OEF/OIF missions also increases the odds of PTSD by the same magnitude 
(OR=3.97, p<0.01).  
The effects of being deployed to Iraq/Afghanistan and on other OEF/OIF missions are 
comparable for the Marines, as it increases the odds of being diagnosed with PTSD by 4.57 and 3.51 
times (p<0.01 for both), respectively.  For the Navy, being deployed to Iraq/Afghanistan also carries 
a very high risk of getting PTSD (OR=9.06, p<0.01) compared to those not deployed under 
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OEF/OIF.  Iraq/Afghanistan missions appear to have the smallest impact for Air Force, as the 
odds of being diagnosed with PTSD among those deployed to Iraq/Afghanistan is only 1.25 times 
higher than those not deployed (p<0.05).  For the Navy and Air Force, the risk of being deployed 
on other OEF/OIF missions is actually lower than for those not deployed on an OEF/OIF mission 
(OR=0.54 and 0.44, respectively, both p<0.01).  
Model 1 also shows that the tour length matters.  Compared to those who have a short tour 
length (<120 days), Army soldiers whose last deployment was between 120-180 days are 1.18 times 
more likely to get PTSD (p<0.01) and those whose last deployment was more than 180 days have an 
odds ratio of 1.62 (p<0.01).   Similar adverse effects of longer tours are observed for the Navy and 
Air Force.  For the Marine Corps, the duration effect only shows up if they have been deployed 
more than 180 days (OR=1.11, p<0.10).  It is worth noting that the adverse effects of deployment 
location and length are present even after we control for MOS, and not surprisingly, those in 
combat arms specialty (the reference group) have the highest odds of being diagnosed with PTSD 
(see the Appendix). 
 For Model 2, presented in the lower panel of Table 3, we add an interaction effect between 
the Iraq/Afghanistan location and the deployment duration variables to test whether long 
deployments exacerbate the effects of deployments to these two countries.  For the Army, the 1.53 
odds ratio on the “long” duration variable now indicates that those whose OEF/OIF deployment to 
locations other than Iraq/Afghanistan lasted more than 180 days are 1.53 times more likely to be 
diagnosed with PTSD than those whose last tour to those locations were under 120 days.  The odds 
ratio on the Iraq/Afghanistan indicator now essentially compares the rate of PTSD between those 
deployed to Iraq/Afghanistan under 120 days and those not deployed to OEF/OIF missions.  Even 
with a short tour, deployment to Iraq still results in an odds ratio of 3.70 (p<0.01).  The same 
applies to the Marine Corps and Navy, but the Air Force still has a smaller effect of an 
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Iraq/Afghanistan deployment.   
The key variables are the last two rows of Model 2.  Among soldiers whose last deployment 
was to Iraq/Afghanistan, those that lasted more than 180 days had a 1.15 times higher risk of being 
diagnosed with PTSD (p<0.10) compared to those with a short (less than 120-day) deployment, 
which is in addition to the main Iraq/Afghanistan effect of 3.96).  For the Army, a medium-length 
deployment had no additional effect on the risk of being diagnosed with PTSD.   We observe 
additive effects for the Navy (OR for the interactive terms on medium and long duration are 2.50 
and 2.47, respectively, p<0.01), but not for the Marine Corps or Air Force. 
Next, due to the potential lags in the onset and diagnosis of PTSD, we examine, in Model 3, how 
previous OEF/OIF deployments affect the probability of being diagnosed with PTSD.   The results 
in Table 5 are similar to Model 1 (where we only capture the location of the last deployment).  The 
odds ratio of being diagnosed with PTSD for those deployed to Iraq/Afghanistan (but not on other 
OEF/OIF missions) compared to those never deployed under OEF/OIF ranges from 1.85 times 
for the Air Force to 10.34 times for the Navy (p<0.01 for all services).  The highest increased risk of 
PTSD occurs for those who were deployed to Iraq/Afghanistan as well as on other OEF/OIF 
missions: the odds ratio of being diagnosed with PTSD ranges from 1.92 for the Air Force to 9.65 
for the Navy (p<0.01 for all services) compared to those never sent on an OEF/OIF missions.   
Model 4, in the bottom panel of Table 5, refines Model 3 further by incorporating frequency 
to a given location.  For example, for Marines (2nd column), being deployed to Afghanistan or Iraq 
(regardless of frequency) increases the odds of getting PTSD by 4.04 times (p<0.01) compared to 
those never deployed to OEF/OIF missions.  But, if the soldier deployed more than once to 
Afghanistan or Iraq, his odds of getting PTSD nearly double, increasing by another 1.91 times 
(p<0.01).  Interestingly, for the Army, there is not an additive effect of more than one deployment 
to Afghanistan or Iraq.  There are, however, similar adverse frequency effects in the other two 
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location categories in Marines and Army.  We do not observe this kind of adverse frequency effect 
for Navy or Air Force. 
In a sensitivity analysis, we address the empirical issue that the year variables could be highly 
correlated with the -OEF/OIF missions, thus causing multicollinearity and perhaps leading to an 
underestimation of the deployment effect on the risk of being diagnosed with PTSD.  Thus we 
estimated models that excluded the year dummies, and the estimated effects of an Iraq/Afghanistan 
deployment on the risk of being diagnosed with PTSD were about 10-15 percent higher than our 
main models. 
Multivariate Analysis of Deployment Intensity on PTSD Rates—Officer Population.  
We next report, in Table 6, the logistic regression results for officers, which is similar to what we 
have in Table 4 for enlisted personnel.  Model 1 (the first panel) indicates that the effect of 
deployment intensity is a lot less severe in the officer population than in the enlisted population, 
with the exception of Marines.  With the Army, the first row indicates that the odds of being 
diagnosed with PTSD is 1.81 times higher (compared to the odds of 3.96 in the enlisted population) 
among those deployed to Iraq/Afghanistan compared to those not deployed under OEF/OIF 
(p<0.01).  Being deployed on other OEF/OIF missions increases the odds of being diagnosed with 
PTSD by a similar magnitude (OR=1.64, p<0.01).  For the Marine officers, being deployed to 
Iraq/Afghanistan increased the odds of PTSD by 3.54 times (p<0.01).  The odds are slightly lower 
(2.13, p<0.05) if the deployment is on other OEF/OIF missions.  For Navy officers, the odds ratio 
is 2.05 for Iraq/Afghanistan deployments, but it is not statistically significant.  Tour length matters 
for Army and Navy officers, but not for Marine or Air Force officers.  A long tour (>180 days) 
carries 2.11 and 2.64 times higher risks of being diagnosed with PTSD for Army and Navy officers, 
respectively.   
 The second panel of Table 6 shows that there is little additive effect of deployment length 
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on the location effect for officers, as long deployments to Iraq and Afghanistan carry similar odds of 
being diagnosed with PTSD as short deployment.  However, it is important to note that for Navy 
officers, due to the small sample size, the interaction term’s coefficient, though having an odds ratio 
of 16.32, also carries an extremely large standard error so that statistical inference is not possible.   
We report the results from Model 3 in the last panel in Table 6.   The location effects are larger than 
those estimated in Model 1 (where we only capture the location of last deployment).  The odds ratio 
of being diagnosed with PTSD for those ever deployed to Iraq/Afghanistan (but not other 
OEF/OIF locations) compared to those never deployed under OEF/OIF ranges from 2.04 times 
for the Marines to 3.66 times for the Navy.  The odds of being diagnosed with PTSD by those who 
were deployed to Iraq/Afghanistan as well as on other OEF/OIF missions ranges from 1.27 for the 
Air Force (not statistically significant) to 5.16 for the Marine (p<0.01) compared to those never sent 
on an OEF/OIF mission.  Due to the sample size, we cannot refine Model 3 further to incorporate 
the frequency of deployments to a given location as we did with the enlisted population.  
 Descriptive Analysis of PTSD Population Comorbidity Distribution.  For the last 
analysis of this report, we focus on just the PTSD population and provide a preliminary analysis of 
the mental health comorbidity in this population.  Table 7 reports the results from the enlisted 
population.  The table is divided into two panels.  The first panel shows the percentage of PTSD 
population with other mental health diagnoses, separately for each service and separately for patients 
who were admitted to inpatient and outpatient settings.  Not surprisingly, patients who were 
diagnosed with PTSD in an inpatient setting have a higher percentage of also having other mental 
health illnesses. Based on the prior literature, we classify the comorbidity into the following 
categories: major depression, substance abuse, other psychosis, other mental health illness, and 
unspecified mental/behavioral problems.(R. Rosenheck & Fontana, 2003)  Among these five 
categories, depression and substance abuse are the top clinical diagnoses—over one third of 
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inpatient patients have depression and 23-39 percent were diagnosed with substance abuse (although 
we cannot ascertain whether the PTSD caused the substance abuse or they were concurrent mental 
health problems).   In addition, 25-33 percent of inpatient patients have other mental health 
illnesses. Among the outpatient PTSD population, 13-20 percent also have depression, 8-26 percent 
were diagnosed with substance abuse, and between a quarter and a third of this population have 
other mental health illnesses.  The distribution of these comorbidity categories is not very different 
across the services.   
Another way to examine the severity of the PTSD case is by looking at number of mental 
health comorbidity in addition to PTSD (second panel of Table 7).  Among the inpatient PTSD 
population, over 85 percent has at least one comorbidity with a substantial minority (14-17 percent, 
depending on the service) having two or more mental health illnesses in addition to PTSD.  Among 
the outpatient PTSD population, between 45 percent (Navy) to 54 percent (Army) have a simple 
case of PTSD without any additional mental health comorbidity, but about 10 percent still have two 
or more additional mental health diagnoses. 
 Table 8 provides the same comorbidity information for the officer population.  Similar to 
the enlisted population, depression remain the top category of comorbidity, and a substantial share 
of PTSD officers also suffer from other mental health illness (that are not substance abuse or 
psychosis).  Unlike the enlisted population, substance abuse is not a common comorbidity of PTSD 
among officers.  The count of comorbidity distribution is also similar.  Among the inpatient PTSD 
population, the majority (ranging from two-thirds in Navy to 100 percent in Marines) have at least 
one comorbidity in addition to PTSD.  Among the outpatient PTSD population, between 55 
percent (Air Force) to 60 percent (Marines) have a simple case of PTSD with no additional mental 
health comorbidity.  Note that the officer PTSD population is a lot smaller (especially among the 
inpatient population), and some of the reported distribution is based on very few cases. 
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Comments 
In this study, we link deployment information and TRICARE health records for a random 
sample of active duty population to examine the relationship between deployment intensity and 
PTSD.  We find that the percentage of PTSD diagnoses among the active duty population varies by 
service, but are all below one percent among those not deployed on OEF/OIF missions.  But, those 
deployed to Iraq/Afghanistan have a much higher probability of being diagnosed with PTSD, with 
the percentages ranging from 1.3% for the Air Force to 6.5% for the Navy in the enlisted 
population, and 1%-2% for the officer population.  Those deployed on other OEF/OIF missions, 
on the other hand, have higher PTSD rates relative to those not deployed on OEF/OIF missions 
only for the Army and Marine Corps.  
While those comparisons describe the actual rates of PTSD across the services for different 
types of deployments, our regression models further explore how the deployment location and 
duration affect the risk of being diagnosed with PTSD, relative to what it would have been in other 
typical world-wide missions of the U.S. military.  A deployment to Iraq/Afghanistan increases the 
odds of being diagnosed with PTSD substantially for the enlisted population, with the largest effect 
observed for the Navy (OR=9.06) and the smallest effect for the Air Force (OR=1.25).  For 
officers, the adverse effects of location are much smaller, ranging from an odds ratio of 1.81 for the 
Army to an odds ratio of 3.54 for the Marines.  The tour length also matters for all services in the 
enlisted population, as a deployment lasting longer than 180 days increases the odds of PTSD by 
1.11 times to 2.84 times, depending on the service, compared to a short tour. Furthermore, for the 
Army and Navy, a deployment to Iraq/Afghanistan further exacerbates the adverse effect of tour 
length.   For the officers population, tour length only appears to matter for Army and Navy, but not 
for Marines nor Air Force.  The sizable adverse effect of deployment location persists when we 
considered all past deployments, not just the previous deployment. 
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Our overall rates of PTSD are much lower than previously reported based on surveys or on 
VA data (Ramchand, et al., 2008). There are several important factors that contribute to the 
differences.  First, our sample is active duty personnel who are still deemed fit to serve in the 
military, whereas people who show up in the VA health care system are those who had left the 
military because they have serious physical or mental health problems that prevent them from 
continuing to serve.  Second, compared to PTSD rates reported in anonymous surveys, which lack 
clinical details in the screening questions, our PTSD rates are based on clinical diagnoses.  Military 
personnel may be more willing to admit to PTSD symptoms, even if they were mild, on an 
anonymous survey than they would to military health officials.  Third, for people who have the 
desire to continue serving (and thus stay within the TRICARE system), the stigma of PTSD often 
prevents them from seeking care when needed since this information would then go on the service 
person’s record.   
 It is also important to keep in mind the following limitations of this study.  First, even 
though we were able to include military occupational specialty categories, we do not have details on 
the specific assignments.  The lack of details on assignments might contribute to the lower odds 
ratios we observe among Navy and Air Force personnel who were deployed on OEF/OIF missions 
that are not in Iraq or Afghanistan.2 Second, since our intention is to look at the prevalence of 
PTSD among the population of personnel who are still in service, we most likely miss severe cases 
of PTSD since those would show up in the VA system unless they were first diagnosed inside the 
TRICARE system.  Lastly, using clinical diagnosis in a system that is not explicitly screening for 
PTSD has its own shortcoming.   For example, using a sample of veterans studied before the VA 
instituted mandatory screening, Magruder and colleagues found that less than 1 in 5 cases of PTSD 
                                            
2 For example, in the Navy the reference group is mostly people on routine shipboard operation (although they 
might also be on their shore rotation).  Personal communications with the sailors reveal that the living condition on ship 
is usually horrendous, and a ground OIF assignment in places like Quatar or Kuwait might actually be better compared 
to life on ship. 
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were detected among those seen only in primary care setting (Magruder, et al., 2004).  Even though 
we have complete history of medical encounters during the study period (both inpatient and 
outpatient records), using clinical diagnoses to identify PTSD population is likely underestimate 
PTSD’s true prevalence among still active population.  However, we don’t expect the degree of 
underestimation to differ by the deployment characteristics, therefore the odds ratios we estimated 
for the effect of deployment intensity on PTSD would not be biased. 
 With these caveats in mind, there are several important policy implications from our 
findings.  First, the adverse effects of deployment location and duration are much larger in the 
enlisted population than in the officer population.  This is most likely due to the differences in the 
tasks assigned to the two populations.  Such findings do raise the question of whether additional 
mental health preparation is needed for the enlisted population.  Second, while the adverse effects of 
Iraq/Afghanistan deployments across all services is expected, it might be surprising that such 
deployments cause the highest PTSD rates for the Navy enlisted personnel.  This might be due to 
many sailors deployed to Iraq or Afghanistan being what the military calls Individual Augmentees 
(IA), who are those deployed individually or in a small group to assist Army and Marines.   The IAs 
are subject to additional stress as they are thrust into an unfamiliar environment away from their 
parent command.   It may be important to train these personnel for not just the additional physical 
skills but also mental health readiness for such assignments.  In addition, the adverse effect of tour 
length is observed across all services in the enlisted population—and for the Air Force, longer 
durations are more likely to lead to PTSD than being deployed in Afghanistan/Iraq.  While a 
recommendation of the optimal tour length for each branch is beyond the scope of this study, our 
findings do suggest that efforts to keep OEF/OIF deployments to reasonable lengths could help 
reduce PTSD rates.  
 Given the continuing nature of the Global War on Terror, it is unavoidable that many still 
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active personnel will be subjected to multiple deployments to OEF/OIF locations.  We can expect 
thousands of new cases of PTSD, and it is imperative to monitor these soldiers’ mental health. The 
DoD has begun to address this issue by introducing the Post-Deployment Health Reassessment 
(PDHRA, DD2900) in March 2005, and DoD mandates the completion of this re-assessment at 90-
180 days after a deployment (US Department of Defense, 2008).  However, our data show that 
almost 75 percent of the PTSD population in our sample did not get diagnosed with PTSD until 200 
days after their last deployment—the average lapse between the last deployment and the first 
diagnosis of PTSD is 291 days.   Further research effort should look into the extent of the effect due 
to repeated deployments and explore how effective PDHRA is in identifying PTSD cases, as well as 
more effective monitoring methods beyond the 180 day mandated surveys. 
 PTSD leads to a host of long-term family and workplace problems and is often associated 
with other psychiatric and physical disorders.  As our descriptive analysis of the PTSD population 
shows, a substantial share of those with PTSD diagnoses has at least one other mental health 
comorbidity condition, with major depression and substance abuse being the top two associated 
diagnoses.  Our research identifies the extent of the PTSD problem within the still active population 
and highlights how certain personnel regardless of their rank, based on their deployment 
characteristics, are at higher risks of developing this disorder.  Further research into preventive 
measures and effective treatments of PTSD on the active duty population, especially the higher risk 
groups, needs to remain a focus within the Department of Defense.  In addition, our study only 
focuses on active duty population and excludes the Reserve population that got activated.  That 
population might have higher propensity of developing mental health illnesses after deployment, 
since their military trainings would not be as comprehensive as the active duty population.  Future 
analysis examining the Reserve components would provide important information on the mental 
health readiness of this increasingly important segment of the military population.  Lastly, while 
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PTSD remains the focus of media attention, other mental health illness such as depression and 
substance abuse have higher prevalence in the active duty population, and are just as costly to the 
individuals, military health system, and the society.  A comprehensive analysis of other mental health 




American Psychiatric Association. (2000). Diagnostic and Statistical Manual of Mental Disorders DSM-IV-
TR. 
CDC. (1988). Health status of Vietnam veterans. I. Psychosocial characteristics. The Centers for 
Disease Control Vietnam Experience Study. JAMA, 259(18), 2701-2707. 
Erbes, C., Westermeyer, J., Engdahl, B., & Johnsen, E. (2007). Post-traumatic stress disorder and 
service utilization in a sample of service members from Iraq and Afghanistan. Military 
medicine, 172(4), 359-363. 
Grieger, T. A., Cozza, S. J., Ursano, R. J., Hoge, C., Martinez, P. E., Engel, C. C., et al. (2006). 
Posttraumatic stress disorder and depression in battle-injured soldiers. The American journal of 
psychiatry, 163(10), 1777-1783; quiz 1860. 
Helzer, J. E., Robins, L. N., & McEvoy, L. (1987). Post-traumatic stress disorder in the general 
population. Findings of the epidemiologic catchment area survey. N Engl J Med, 317(26), 
1630-1634. 
Hoge, C. W., Auchterlonie, J. L., & Milliken, C. S. (2006). Mental health problems, use of mental 
health services, and attrition from military service after returning from deployment to Iraq or 
Afghanistan. JAMA, 295(9), 1023-1032. 
Hoge, C. W., Castro, C. A., Messer, S. C., McGurk, D., Cotting, D. I., & Koffman, R. L. (2004). 
Combat duty in Iraq and Afghanistan, mental health problems, and barriers to care. N Engl J 
Med, 351(1), 13-22. 
Kang, H. K., Natelson, B. H., Mahan, C. M., Lee, K. Y., & Murphy, F. M. (2003). Post-traumatic 
stress disorder and chronic fatigue syndrome-like illness among Gulf War veterans: a 
population-based survey of 30,000 veterans. Am J Epidemiol, 157(2), 141-148. 
Kimerling, R., Ouimette, P., Prins, A., Nisco, P., Lawler, C., Cronkite, R., et al. (2006). Brief report: 
Utility of a short screening scale for DSM-IV PTSD in primary care. Journal of general internal 
medicine, 21(1), 65-67. 
Martin, C. (2007). Routine screening and referrals for PTSD after returning from Operation Iraqi 
Freedom in 2005. U.S. Armed Forces Medical Surveillance Monthly Report 14(6), 2-7. 
Prigerson, H. G., Maciejewski, P. K., & Rosenheck, R. A. (2002). Population attributable fractions of 
psychiatric disorders and behavioral outcomes associated with combat exposure among US 
men. American journal of public health, 92(1), 59-63. 
Ramchand, R., Karney, B. R., Osilla, K. C., Burns, R. M., & Caldarone, L. B. (2008). Prevalence of 
PTSD, Depression, and TBI among Returning Service members. In T. Tanielian & L. H. 
Jaycox (Eds.), Invisible Wounds of War: Psychological and Cognitive Injuries, Their Consequences, and 
Services to Assist Recovery (pp. 35-84). Santa Monica: Rand Corporation. 
Rona, R. J., Fear, N. T., Hull, L., Greenberg, N., Earnshaw, M., Hotopf, M., et al. (2007). Mental 
health consequences of overstretch in the UK armed forces: first phase of a cohort study. 
BMJ, 335(7620), 603. 
Rosenheck, R., & Fontana, A. (2003). Use of mental health services by veterans with PTSD after the 
terrorist attacks of September 11. Am J Psychiatry, 160(9), 1684-1690. 
Rosenheck, R. A., & Fontana, A. F. (2007). Recent trends In VA treatment of post-traumatic stress 
disorder and other mental disorders. Health affairs (Project Hope), 26(6), 1720-1727. 
Seal, K. H., Bertenthal, D., Miner, C. R., Sen, S., & Marmar, C. (2007). Bringing the war back home: 
mental health disorders among 103,788 US veterans returning from Iraq and Afghanistan 
seen at Department of Veterans Affairs facilities. Arch Intern Med, 167(5), 476-482. 
Shen, Y. C., Arkes, J., & Pilgrim, J. (2009). The effects of deployment intensity on post-traumatic 
stress disorder: 2002-2006. Military medicine, 174(3), 217-223. 
 22
 23
Tanielian, T., & Jaycox, L. H. (2008). Invisible Wounds of War: Psychological and Cognitive Injuries, Their 
Consequences, and Services to Assist Recovery: Rand Corporation. 
The Iowa Persian Gulf Study Group. (1997). Self-reported illness and health status among Gulf War 
veterans. A population-based study. The Iowa Persian Gulf Study Group. JAMA, 277(3), 
238-245. 
U.S. Army. (2003, Jan 1). Operation Iraqi Freedom (OIF) Mental Health Advisory Team (MHAT) 
Report.   Retrieved May 11, 2009, from 
http://www.armymedicine.army.mil/reports/mhat/mhat/mhat_report.pdf 
U.S. Army. (2005, January 30, 2005). Operation Iraqi Freedom (OIF) Mental Health Advisory Team 
(MHAT-II) Report.   Retrieved May 11, 2009, from 
http://www.armymedicine.army.mil/reports/mhat/mhat_ii/OIF-II_REPORT.pdf 
U.S. Army. (2006a, May 29, 2006). Operation Iraqi Freedom (OIF) Mental Health Advisory Team 
(MHAT-III) Report.   Retrieved May 11, 2009, from 
http://www.armymedicine.army.mil/reports/mhat/mhat_iii/MHATIII_Report_29May200
6-Redacted.pdf 
U.S. Army. (2006b, November 17, 2006). Operation Iraqi Freedom (OIF) Mental Health Advisory 
Team (MHAT-IV) Report.   Retrieved May 11, 2009, from 
http://www.armymedicine.army.mil/reports/mhat/mhat_iv/MHAT_IV_Report_17NOV0
6.pdf 
US Department of Defense. (2008, October 14, 2008). Post-Deployment Health Reassessment 
(PDHRA) Program (DD Form 2900).   Retrieved October 14, 2008, from 
http://www.pdhealth.mil/dcs/pdhra.asp  
Vasterling, J. J., Proctor, S. P., Amoroso, P., Kane, R., Heeren, T., & White, R. F. (2006). 
Neuropsychological outcomes of army personnel following deployment to the Iraq war. 




Table 1.Descriptive Statistics of Enlisted Personnel Characteristics 
  Army Marines Navy Air Force 
Deployment Characteristics     
Location of Last OEF/OIF Deployment     
Not deployed under OEF/OIF 77.9% 75.3% 64.3% 61.5%
Afghanistan or Iraq 11.3% 8.6% 1.0% 5.4%
Other countries under OEF/OIF 10.8% 16.0% 34.7% 33.1%
Duration of Last OEF/OIF Deployment     
Short (1-120 days) 28.0% 25.6% 31.4% 64.5%
Medium (120-180 days) 14.2% 26.0% 23.2% 24.7%
Long (more than 180 days) 57.7% 48.4% 45.4% 10.8%
Deployment History     
Ever deployed under OEF/OIF 22.1% 24.7% 35.7% 38.5%
Ever deployed to Afghanistan or Iraq 
only 31.4% 22.2% 2.0% 9.4%
Ever deployed to other OEF/OIF 
countries except Afghanistan or Iraq 45.0% 64.2% 97.0% 84.9%
Ever deployed to Afghanistan or Iraq, 
and other OEF/OIF countries 23.6% 13.6% 1.0% 5.7%
Service Characteristics     
Military Occupational Specialty*     
Combat Arms 28.9% 38.4% 4.9% 10.6%
Combat Support 10.9% 16.8% 10.0% 0.2%
Combat Service Support 26.7% 28.0% 5.6% 79.0%
Aviation - 15.0% 3.4% - 
Medical 10.1% - 3.0% - 
Other MOS 23.0% 1.3% 72.8% 9.8%
Rank     
E1-E3 33.6% 61.4% 38.2% 32.4%
E4 28.0% 17.0% 19.9% 18.7%
E5 17.4% 11.0% 20.4% 23.0%
E6 11.1% 5.6% 13.7% 14.5%
E7-E9 8.0% 4.4% 7.3% 11.5%
Demographic Characteristics     
Gender     
Male 88.7% 96.3% 87.4% 84.1%
Female 11.3% 3.7% 12.6% 15.9%
Marital Status     
Single 53.0% 69.0% 55.0% 48.2%
Married 47.0% 31.0% 45.0% 51.8%
Race     
White 63.9% 71.2% 57.2% 74.0%
Black 19.5% 10.3% 21.7% 15.3%
Hispanic 6.8% 8.2% 7.2% 3.4%
Asian 3.9% 2.8% 6.0% 2.2%
Other races 5.9% 7.6% 8.0% 5.0%
Age 27.7 23.4 27.0 28.5




Table 2.Descriptive Statistics of Officer Personnel Characteristics 
  Army Marines Navy Air Force 
Deployment Characteristics     
Location of Last OEF/OIF Deployment     
Not deployed under OEF/OIF 74.7% 71.0% 67.0% 62.5%
Afghanistan or Iraq 10.5% 9.0% 1.6% 4.6%
Other countries under OEF/OIF 14.8% 20.0% 31.4% 32.9%
Duration of Last OEF/OIF Deployment     
Short (1-120 days) 36.6% 32.5% 42.2% 72.2%
Medium (120-180 days) 13.6% 24.2% 20.8% 19.3%
Long (more than 180 days) 49.8% 43.4% 37.0% 8.5%
Deployment History     
Ever deployed under OEF/OIF 25.3% 29.0% 33.0% 37.5%
Ever deployed to Afghanistan or Iraq 
only 27.0% 18.4% 3.7% 8.4%
Ever deployed to other OEF/OIF 
countries except Afghanistan or Iraq 55.3% 68.0% 94.8% 86.3%
Ever deployed to Afghanistan or Iraq, 
and other OEF/OIF countries 17.7% 13.5% 1.5% 5.2%
Service Characteristics     
Military Occupational Specialty*     
Combat Arms 32.7% 29.3% 1.3% 0.4%
Combat Support 16.4% 6.7% 8.1% 0.2%
Combat Service Support 18.5% 27.9% 88.6% 1.2%
Aviation  31.7% 0.5%  
Medical 12.7%  0.1%  
Other MOS 19.4% 4.3% 2.1% 98.0%
Rank     
O1_O2 34.2% 36.5% 33.5% 30.4%
O3 31.9% 28.7% 31.3% 31.6%
O4 20.4% 19.7% 20.3% 22.4%
O5 9.9% 11.2% 11.2% 12.3%
O6_O10 3.6% 3.9% 3.7% 3.3%
Demographic Characteristics     
Gender     
Male 87.5% 94.6% 88.4% 86.1%
Female 12.5% 5.4% 11.6% 13.9%
Marital Status     
Single 34.3% 36.4% 39.8% 31.4%
Married 65.7% 63.6% 60.2% 68.6%
Race     
White 77.5% 83.6% 82.2% 85.1%
Black 11.3% 5.5% 7.3% 5.3%
Hispanic 2.9% 2.8% 4.3% 1.7%
Asian 4.0% 2.0% 3.8% 2.0%
Other races 4.4% 6.2% 2.4% 5.8%
Age 34.4 32.9 33.9 34.4




Table 3. Rate of PTSD Diagnoses By Deployment Location 
  Army Marines Navy Air Force 
Enlisted Population     
Overall 1.40% 1.06% 0.77% 0.56%
     
Based on Location of Last OEF/OIF Deployment 
Not deployed under OEF/OIF 0.63 0.52 0.83 0.62
Afghanistan or Iraq 4.41 3.51 6.46 1.34
Other countries under OEF/OIF 3.77 2.28 0.49 0.31
Based on Duration of Last OEF/OIF Deployment 
Short (1-120 days) 2.90 2.31 0.50 0.31
Medium (120-180 days) 3.49 2.22 0.66 0.62
Long (more than 180 days) 4.83 3.19 0.77 0.99
Based on Deployment History     
Not deployed under OEF/OIF 0.63 0.52 0.83 0.62
Ever deployed under OEF/OIF 4.10 2.71 0.66 0.46
Ever deployed to Afghanistan or Iraq 
only 3.48 2.76 6.32 1.27
Ever deployed to other OEF/OIF 
countries except Afghanistan or Iraq 3.43 2.19 0.49 0.31
Ever deployed to Afghanistan or Iraq, 
and other OEF/OIF countries 6.20 5.14 6.06 1.36
Sample Size 332970 98695 134095 112467
Officer Population     
Overall 0.66% 0.36% 0.31% 0.29%
     
Based on Location of Last OEF/OIF Deployment 
Not deployed under OEF/OIF 0.39 0.22 0.34 0.32
Afghanistan or Iraq 1.64 1.03 1.43 0.94
Other countries under OEF/OIF 1.31 0.57 0.19 0.15
Based on Duration of Last OEF/OIF Deployment 
Short (1-120 days) 0.90 0.63 0.17 0.17
Medium (120-180 days) 1.32 0.79 0.32 0.46
Long (more than 180 days) 1.88 0.73 0.30 0.48
Based on Deployment History     
Not deployed under OEF/OIF 0.39 0.22 0.34 0.32
Ever deployed under OEF/OIF 1.45 0.71 0.25 0.25
Ever deployed to Afghanistan or Iraq 
only 1.26 0.69 1.33 1.05
Ever deployed to other OEF/OIF 
countries except Afghanistan or Iraq 1.24 0.52 0.19 0.15
Ever deployed to Afghanistan or Iraq, 
and other OEF/OIF countries 2.38 1.69 1.36 0.53




Table 4. Effect of Last Deployment's Location and Duration on the Rate of PTSD Diagnoses--
Enlisted Population 
  Army Marines Navy Air 
Force 
Model 1: Main Effect     
Location of Last Deployment (reference group is not deployed under OEF/OIF) 
Deployed to Afghanistan or Iraq 3.96** 4.57** 9.06** 1.25* 
 (0.12) (0.32) (1.10) (0.11) 
Deployed to other countries under OEF/OIF 3.97** 3.51** 0.54** 0.36** 
 (0.11) (0.21) (0.04) (0.02) 
Duration of Last Deployment (reference group is short, <120 days) 
Medium (120-180 days) 1.18** 0.95 1.19+ 1.72** 
 (0.04) (0.06) (0.12) (0.14) 
Long (longer than 180 days) 1.62** 1.11+ 1.21* 2.84** 
  (0.04) (0.06) (0.11) (0.28) 
Model 2: Interactive Effect     
Location of Last Deployment (reference group is not deployed under OEF/OIF) 
Deployed to Afghanistan or Iraq 3.70** 5.37** 4.53** 1.25+ 
 (0.17) (0.51) (1.38) (0.14) 
Deployed to other countries under OEF/OIF 4.07** 3.32** 0.59** 0.36** 
 (0.12) (0.22) (0.04) (0.02) 
Duration of Last Deployment (reference group is short, <120 days) 
Medium (120-180 days) 1.21** 0.97 1.07 1.70** 
 (0.06) (0.07) (0.11) (0.17) 
Long (longer than 180 days) 1.53** 1.28** 1.07 2.89** 
 (0.05) (0.09) (0.10) (0.34) 
Interaction Between Deployment Duration and Iraq/Afghanistan Location 
Medium duration X Iraq or Afghanistan 0.97 0.99 2.50* 1.02 
 (0.08) (0.15) (0.96) (0.18) 
Long duration X Iraq or Afghanistan 1.15* 0.71** 2.47** 0.96 
 (0.07) (0.08) (0.82) (0.20) 
Sample size 332970 98695 134095 112467
     
Note: Full regression results for Model 1 is in the Appendix. 




Table 5. Effect of Deployment History on the Rate of PTSD Diagnoses--Enlisted Population 
  Army Marines Navy Air Force 
Model 3: Past Deployment Countries     
Deployment History (reference group is never deployed under OEF/OIF) 
Ever deployed to Afghanistan or Iraq only 4.61** 4.09** 10.34** 1.85** 
 (0.12) (0.23) (1.20) (0.15) 
Ever deployed to other OEF/OIF countries 
except Afghanistan or Iraq 4.64** 3.48** 0.61** 0.47** 
 (0.10) (0.16) (0.03) (0.03) 
Ever deployed to Afghanistan, Iraq, and other 
countries under OEF/OIF 8.34** 7.10** 9.65** 1.92** 
  (0.20) (0.42) (1.74) (0.19) 
Model 4: Past Deployment Frequency      
Deployment History (reference group is never deployed under OEF/OIF) 
Deployed at least once to Afghanistan or Iraq 
only 4.62** 4.04** 10.15** 1.88** 
 (0.12) (0.23) (1.21) (0.16) 
Deployed more than once to Afghanistan or 
Iraq only 0.99 1.91** 1.43 0.74 
 (0.07) (0.31) (0.64) (0.26) 
Deployed at least once to other countries 
under OEF/OIF except AF or Iraq 4.54** 2.98** 0.61** 0.50** 
 (0.10) (0.15) (0.03) (0.03) 
Deployed more than once to other countries 
under OEF/OIF except AF or Iraq 1.19** 2.29** 1.07 0.78* 
 (0.05) (0.17) (0.10) (0.08) 
Deployed at least once to Afghanistan, Iraq, 
and other countries 8.15** 7.31** 9.66** 2.01** 
 (0.20) (0.44) (1.76) (0.20) 
Deployed more than once to Afghanistan, Iraq, 
and more than once to other countries 2.20** 2.12* 1.08 0.33* 
 (0.20) (0.70) (1.24) (0.17) 
Sample size 332970 98695 134095 112467
     
Full results are available upon request     





Table 6. Effect of Last Deployment's Location and Duration on the Rate of PTSD Diagnoses--
Officer Population 
  Army Marines Navy Air Force 
Model 1: Main Effect     
Location of Last Deployment (reference group is not deployed under OEF/OIF) 
Deployed to Afghanistan or Iraq 1.81** 3.54** 2.05 2.15* 
 (0.24) (1.50) (1.33) (0.73) 
Deployed to other countries under OEF/OIF 1.64** 2.13* 0.54 0.34** 
 (0.18) (0.68) (0.23) (0.07) 
Duration of Last Deployment (reference 
group is short, <120 days)     
Medium (120-180 days) 1.54** 1.07 1.34 1.81+ 
 (0.24) (0.42) (0.96) (0.60) 
Long (longer than 180 days) 2.11** 0.73 2.64* 0.60 
  (0.24) (0.27) (1.21) (0.38) 
Model 2: Interactive Effect     
Location of Last Deployment (reference group is not deployed under OEF/OIF) 
Deployed to Afghanistan or Iraq 2.11** 5.95** 0.34 3.75** 
 (0.41) (2.77) (0.54) (1.05) 
Deployed to other countries under OEF/OIF 1.57** 1.62 0.69 0.26** 
 (0.19) (0.63) (0.25) (0.07) 
Duration of Last Deployment (reference group is short, <120 days) 
Medium (120-180 days) 1.68** 1.85 1.27 3.41** 
 (0.32) (0.85) (0.90) (1.33) 
Long (longer than 180 days) 2.25** 0.93 1.62 1.53 
 (0.31) (0.46) (0.71) (1.01) 
Interaction Between Deployment Duration and Iraq/Afghanistan Location 
Medium duration X Iraq or Afghanistan 0.75 0.13* 3.07 0.25* 
 (0.25) (0.13) (6.83) (0.15) 
Long duration X Iraq or Afghanistan 0.79 0.48 16.32 0.08* 
 (0.19) (0.34) (28.08) (0.10) 
Model 3: Past Deployment Countries         
Deployment History (reference group is never deployed under OEF/OIF) 
Ever deployed to Afghanistan or Iraq only 2.54** 2.04+ 3.66* 3.08** 
 (0.28) (0.85) (2.24) (1.11) 
Ever deployed to other OEF/OIF countries 
except Afghanistan or Iraq 2.29** 1.83* 0.83 0.36** 
 (0.19) (0.52) (0.22) (0.07) 
Ever deployed to Afghanistan, Iraq, and other 
countries under OEF/OIF 4.84** 5.16** 3.38 1.27 
  (0.51) (1.82) (3.39) (0.57) 
Sample size 48952 8927 15438 22556
     
Note: Full regression results for Model 1 is in the Appendix. 
** p<0.01, * p<0.05,+ p<0.10     
 
Table 7. Comorbidity Distribution By Services--Enlisted PTSD Population 
         
  Army Marines Navy Air Force 
 Inpatient Outpatient Inpatient Outpatient Inpatient Outpatient Inpatient Outpatient
Mental Health Illness Indicators (in percentage) 
 
Depression  35.3 12.6 30.0 16.4 34.2 17.3 46.5 20.1 
Substance Abuse  30.2 10.7 39.0 15.2 25.7 12.3 23.1 8.1 
Other Psychosis  10.9 3.4 7.8 2.8 7.1 3.7 11.4 3.3 
Other Mental Illness  24.9 30.7 24.6 27.2 33.5 35.9 26.0 30.0 
Unspecified mental and 
behavioral problems (V40) 0.00 0.08 0.00 0.09 0.00 0.04 0.00 0.03 
Count of Mental Illness Comorbidity (in percentage) 
  
0 16.7 54.3 15.0 51.7 13.4 44.7 10.5 50.8 
1 66.6 35.7 69.0 37.0 73.0 43.3 73.1 38.8 
2 15.5 8.3 15.8 9.5 13.4 10.1 15.2 8.7 
>2 1.22 1.66 0.26 1.83 0.22 1.90 1.17 1.71 





Table 8. Comorbidity Distribution By Services--Officer PTSD Population 
         
  Army Marines Navy Air Force 
 Inpatient Outpatient Inpatient Outpatient Inpatient Outpatient Inpatient Outpatient
Mental Health Illness Indicators (in percentage) 
 
Depression  59.7 16.6 71.4 23.0 26.7 17.3 47.8 21.1 
Substance Abuse  17.9 4.2 42.9 6.4 13.3 6.1 21.7 3.8 
Other Psychosis  11.9 2.7 14.3 4.8 6.7 4.4 8.7 1.9 
Other Mental Illness  17.9 27.6 28.6 19.1 26.7 28.1 26.1 30.4 
Unspecified mental and 
behavioral problems  0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 
Count of Mental Illness Comorbidity (in percentage) 
  
0 11.9 58.0 0.0 60.3 33.3 56.6 17.4 54.7 
1 68.7 33.7 57.1 28.6 60.0 32.9 69.6 35.2 
2 19.4 7.7 28.6 8.7 6.7 8.8 8.7 8.4 
>2 0.00 0.67 14.29 2.38 0.00 1.70 4.35 1.63 
Number of Individuals 67 1202 7 126 15 295 23 369 
Appendix A. Effect of Deployment Location and Duration on the Rate of PTSD Diagnoses--Enlisted 
Population 
  Army Marines Navy Air Force 
Location of Last Deployment (reference group is not deployed under OEF/OIF) 
Deployed to Afghanistan or Iraq 3.96** 4.57** 9.06** 1.25* 
 (0.12) (0.32) (1.10) (0.11) 
Deployed to other countries under OEF/OIF 3.97** 3.51** 0.54** 0.36** 
 (0.11) (0.21) (0.04) (0.02) 
Duration of Last Deployment (reference group is short, <120 days) 
Medium (120-180 days) 1.18** 0.95 1.19+ 1.72** 
 (0.04) (0.06) (0.12) (0.14) 
Long (longer than 180 days) 1.62** 1.11+ 1.21* 2.84** 
 (0.04) (0.06) (0.11) (0.28) 
Military Occupational Specialty (reference group is Combat Arms) 
Combat Support 0.29** 0.35** 0.02**  
 (0.01) (0.02) (0.00)  
Combat Service Support 0.33** 0.37** 0.03** 0.09** 
 (0.01) (0.02) (0.00) (0.00) 
Aviation - 0.22** 0.02** - 
  (0.02) (0.00)  
Medical 0.31** - 0.16** - 
 (0.01)  (0.01)  
Other MOS 0.34** 0.47** 0.03** 0.11** 
 (0.01) (0.07) (0.00) (0.01) 
Rank (reference group is E1-E3)     
E4 1.22** 0.93 0.72** 1.07 
 (0.03) (0.04) (0.04) (0.06) 
E5 1.00 0.88* 0.41** 1.00 
 (0.03) (0.05) (0.03) (0.07) 
E6 0.73** 0.46** 0.23** 0.68** 
 (0.03) (0.04) (0.02) (0.06) 
E7-E9 0.57** 0.26** 0.16** 0.70** 
 (0.02) (0.03) (0.02) (0.08) 
Demographics     
race (reference group is White)     
African-American 0.88** 0.95 0.73** 0.92 
 (0.02) (0.06) (0.04) (0.05) 
Hispanic 0.81** 0.84** 1.06 1.16 
 (0.03) (0.05) (0.07) (0.11) 
Asian 0.57** 0.75* 0.69** 0.64** 
 (0.03) (0.09) (0.06) (0.10) 
Other races 0.98 0.97 1.18* 1.13 
 (0.03) (0.06) (0.07) (0.09) 
Gender (reference group is male)     
Female 2.96** 6.34** 4.90** 5.20** 
 (0.08) (0.41) (0.19) (0.20) 
Marital status (reference group is married)     
Single 0.64** 0.56** 0.75** 0.76** 
 (0.01) (0.02) (0.03) (0.03) 
Age 1.04** 1.07** 1.06** 1.03** 
 (0.00) (0.01) (0.00) (0.00) 
Sample size 332970 98695 134095 112467




Appendix B. Effect of Deployment Location and Duration on the Rate of PTSD Diagnoses--Officer 
Population 
  Army Marines Navy Air Force 
Location of Last Deployment (reference group is not deployed under OEF/OIF) 
Deployed to Afghanistan or Iraq 1.81** 3.54** 2.05 2.15* 
 (0.24) (1.50) (1.33) (0.73) 
Deployed to other countries under OEF/OIF 1.64** 2.13* 0.54 0.34** 
 (0.18) (0.68) (0.23) (0.07) 
Duration of Last Deployment (reference group is short, <120 days) 
Medium (120-180 days) 1.54** 1.07 1.34 1.81+ 
 (0.24) (0.42) (0.96) (0.60) 
Long (longer than 180 days) 2.11** 0.73 2.64* 0.60 
 (0.24) (0.27) (1.21) (0.38) 
Military Occupational Specialty (reference group is Combat Arms) 
Combat Support 0.36** 0.19** 0.00**  
 (0.04) (0.12) (0.00)  
Combat Service Support 0.26** 0.40** 0.00** 0.00** 
 (0.03) (0.12) (0.00) (0.00) 
Aviation  0.37**   
  (0.10)   
Medical 0.29**    
 (0.04)    
Other MOS 0.25** 0.03** 0.00** 0.00** 
 (0.03) (0.03) (0.00) (0.00) 
Rank (reference group is O1-O2)     
O3 1.09 1.09 3.93** 3.33** 
 (0.11) (0.35) (1.50) (0.90) 
O4 0.63** 0.39* 1.20 2.69** 
 (0.08) (0.17) (0.55) (0.83) 
O5 0.53** 0.23** 0.39+ 4.62** 
 (0.08) (0.12) (0.21) (1.57) 
O6_O10 0.34** 0.46 0.29* 4.38** 
 (0.07) (0.30) (0.16) (1.90) 
Demographics     
race (reference group is White)     
African-American 1.22* 0.44 0.82 1.25 
 (0.12) (0.26) (0.34) (0.37) 
Hispanic 1.28 0.62 1.76+ 1.27 
 (0.22) (0.45) (0.55) (0.55) 
Asian 0.75 0.43 1.49 1.38 
 (0.15) (0.44) (0.55) (0.56) 
Other races 1.41* 0.68 2.00+ 1.39 
 (0.20) (0.35) (0.84) (0.42) 
Gender (reference group is male)     
Female 4.79** 4.78** 3.82** 2.42** 
 (0.46) (1.73) (0.82) (0.42) 
Marital status (reference group is married)     
Single 0.95 0.89 0.73 1.29 
 (0.07) (0.23) (0.15) (0.22) 
Age 1.10** 1.14** 1.18** 1.04** 
Sample size 48952 8927 15438 22556
Note: Year dummies are included. ** p<0.01, * p<0.05,+ p<0. 
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